Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IONS |
---|---|---|
09:32 ET | 11232 | 41.225 |
09:34 ET | 2151 | 41.15 |
09:36 ET | 832 | 40.93 |
09:38 ET | 200 | 40.875 |
09:41 ET | 100 | 40.75 |
09:43 ET | 1678 | 40.815 |
09:45 ET | 800 | 40.9 |
09:50 ET | 1850 | 41.01 |
09:52 ET | 1912 | 40.84 |
09:54 ET | 569 | 40.84 |
09:57 ET | 1290 | 40.8 |
09:59 ET | 100 | 40.84 |
10:01 ET | 725 | 40.77 |
10:03 ET | 976 | 40.75 |
10:06 ET | 500 | 40.81 |
10:08 ET | 900 | 40.84 |
10:10 ET | 1600 | 40.77 |
10:12 ET | 1600 | 40.77 |
10:14 ET | 765 | 40.79 |
10:15 ET | 1442 | 40.825 |
10:17 ET | 100 | 40.81 |
10:19 ET | 669 | 40.76 |
10:21 ET | 413 | 40.77 |
10:24 ET | 40880 | 40.68 |
10:26 ET | 26106 | 40.755 |
10:28 ET | 200 | 40.71 |
10:30 ET | 829 | 40.8 |
10:32 ET | 638 | 40.86 |
10:33 ET | 700 | 40.93 |
10:35 ET | 1131 | 40.845 |
10:37 ET | 620 | 40.88 |
10:39 ET | 638 | 40.91 |
10:42 ET | 300 | 40.91 |
10:44 ET | 100 | 40.91 |
10:46 ET | 1308 | 40.8 |
10:48 ET | 300 | 40.82 |
10:50 ET | 348 | 40.81 |
10:51 ET | 400 | 40.85 |
10:53 ET | 300 | 40.825 |
10:55 ET | 208 | 40.85 |
10:57 ET | 520 | 40.83 |
11:00 ET | 914 | 40.8675 |
11:02 ET | 4863 | 40.825 |
11:04 ET | 1767 | 40.89 |
11:06 ET | 344 | 40.97 |
11:08 ET | 100 | 40.91 |
11:09 ET | 388 | 40.85 |
11:11 ET | 200 | 40.82 |
11:13 ET | 1435 | 40.81 |
11:15 ET | 300 | 40.76 |
11:18 ET | 653 | 40.79 |
11:20 ET | 1048 | 40.74 |
11:22 ET | 100 | 40.72 |
11:24 ET | 800 | 40.68 |
11:26 ET | 12533 | 40.64 |
11:27 ET | 1725 | 40.68 |
11:29 ET | 900 | 40.64 |
11:31 ET | 100 | 40.655 |
11:33 ET | 2754 | 40.775 |
11:36 ET | 343 | 40.76 |
11:38 ET | 316 | 40.69 |
11:40 ET | 200 | 40.725 |
11:42 ET | 200 | 40.7 |
11:44 ET | 300 | 40.66 |
11:45 ET | 400 | 40.67 |
11:47 ET | 362 | 40.67 |
11:49 ET | 500 | 40.71 |
11:51 ET | 2042 | 40.79 |
11:54 ET | 1100 | 40.77 |
11:58 ET | 1364 | 40.7722 |
12:00 ET | 600 | 40.75 |
12:02 ET | 100 | 40.75 |
12:03 ET | 300 | 40.755 |
12:05 ET | 400 | 40.75 |
12:07 ET | 1000 | 40.79 |
12:09 ET | 300 | 40.79 |
12:12 ET | 200 | 40.805 |
12:14 ET | 1195 | 40.84 |
12:16 ET | 289 | 40.84 |
12:18 ET | 400 | 40.86 |
12:20 ET | 100 | 40.9 |
12:21 ET | 1100 | 40.87 |
12:23 ET | 100 | 40.81 |
12:25 ET | 300 | 40.83 |
12:27 ET | 300 | 40.77 |
12:30 ET | 200 | 40.755 |
12:32 ET | 422 | 40.735 |
12:36 ET | 200 | 40.76 |
12:38 ET | 683 | 40.75 |
12:41 ET | 200 | 40.73 |
12:43 ET | 200 | 40.745 |
12:48 ET | 100 | 40.77 |
12:52 ET | 1677 | 40.695 |
12:54 ET | 426 | 40.67 |
12:56 ET | 300 | 40.66 |
12:57 ET | 600 | 40.665 |
12:59 ET | 23802 | 41.06 |
01:01 ET | 100 | 41.1 |
01:03 ET | 1000 | 40.99 |
01:06 ET | 1057 | 41.05 |
01:08 ET | 200 | 41.06 |
01:10 ET | 100 | 41.0222 |
01:12 ET | 100 | 41 |
01:14 ET | 100 | 40.96 |
01:19 ET | 400 | 40.96 |
01:21 ET | 1532 | 40.94 |
01:24 ET | 1200 | 40.9 |
01:26 ET | 300 | 40.9 |
01:28 ET | 260 | 40.93 |
01:30 ET | 100 | 40.93 |
01:32 ET | 685 | 40.95 |
01:33 ET | 218 | 40.93 |
01:39 ET | 400 | 40.89 |
01:42 ET | 1609 | 40.85 |
01:44 ET | 9303 | 40.79 |
01:46 ET | 700 | 40.78 |
01:48 ET | 900 | 40.775 |
01:50 ET | 508 | 40.765 |
01:51 ET | 200 | 40.72 |
01:53 ET | 200 | 40.75 |
01:55 ET | 1673 | 40.69 |
01:57 ET | 600 | 40.64 |
02:00 ET | 1423 | 40.625 |
02:02 ET | 924 | 40.48 |
02:04 ET | 2460 | 40.43 |
02:06 ET | 4725 | 40.53 |
02:08 ET | 34862 | 40.525 |
02:09 ET | 1100 | 40.515 |
02:11 ET | 1300 | 40.525 |
02:13 ET | 600 | 40.535 |
02:15 ET | 1300 | 40.615 |
02:18 ET | 7807 | 40.56 |
02:20 ET | 11950 | 40.525 |
02:22 ET | 19213 | 40.48 |
02:24 ET | 14800 | 40.535 |
02:26 ET | 13102 | 40.52 |
02:27 ET | 1130 | 40.565 |
02:29 ET | 1100 | 40.62 |
02:31 ET | 1500 | 40.68 |
02:33 ET | 10800 | 40.74 |
02:36 ET | 1700 | 40.77 |
02:38 ET | 3397 | 40.74 |
02:40 ET | 1100 | 40.77 |
02:42 ET | 1300 | 40.77 |
02:44 ET | 1100 | 40.768 |
02:45 ET | 1013 | 40.77 |
02:47 ET | 700 | 40.75 |
02:49 ET | 1600 | 40.76 |
02:51 ET | 2876 | 40.695 |
02:54 ET | 1800 | 40.69 |
02:56 ET | 3312 | 40.69 |
02:58 ET | 7374 | 40.79 |
03:00 ET | 1100 | 40.78 |
03:02 ET | 16547 | 40.8 |
03:03 ET | 1717 | 40.88 |
03:05 ET | 2645 | 40.8831 |
03:07 ET | 975 | 40.97 |
03:09 ET | 3479 | 41.09 |
03:12 ET | 3683 | 41.134 |
03:14 ET | 500 | 41.16 |
03:16 ET | 10747 | 40.9 |
03:18 ET | 800 | 40.85 |
03:20 ET | 1908 | 40.84 |
03:21 ET | 3381 | 40.76 |
03:23 ET | 3400 | 40.775 |
03:25 ET | 1574 | 40.83 |
03:27 ET | 2199 | 40.87 |
03:30 ET | 3977 | 40.95 |
03:32 ET | 5948 | 40.97 |
03:34 ET | 3615 | 40.99 |
03:36 ET | 1576 | 40.98 |
03:38 ET | 4774 | 40.99 |
03:39 ET | 5333 | 41.035 |
03:41 ET | 4100 | 41.05 |
03:43 ET | 16144 | 41.065 |
03:45 ET | 6269 | 40.99 |
03:48 ET | 3273 | 40.85 |
03:50 ET | 5243 | 40.78 |
03:52 ET | 9534 | 40.78 |
03:54 ET | 66458 | 40.58 |
03:56 ET | 60889 | 40.48 |
03:57 ET | 95571 | 40.55 |
03:59 ET | 294789 | 40.65 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ionis Pharmaceuticals Inc | 6.0B | -15.2x | --- |
Halozyme Therapeutics Inc | 6.3B | 20.5x | --- |
CRISPR Therapeutics AG | 5.5B | -23.5x | --- |
Intra-Cellular Therapies Inc | 7.2B | -58.8x | --- |
Apellis Pharmaceuticals Inc | 5.2B | -12.1x | --- |
Guardant Health Inc | 3.9B | -7.7x | --- |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.9B |
---|---|
Revenue (TTM) | $776.6M |
Shares Outstanding | 146.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.37 |
EPS | $-2.67 |
Book Value | $2.68 |
P/E Ratio | -15.2x |
Price/Sales (TTM) | 7.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -48.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.